IL6 and inflammatory bowel disease: Thus, normalization of the increased levels of IL-6, IL-23, RORγt, and STAT3 may be crucial to inhibit the differentiation of Th17 cells and, given their prominent role in IBD pathogenesis, may prevent or at least alleviate the symptoms of intestinal inflammation.